The prostate is a walnut-sized gland located between the bladder and the penis. The prostate secretes fluid that nourishes and protects sperms. A prostate biopsy is very important in the diagnosis and treatment of prostate cancer. Prostate biopsy is a procedure to remove samples of suspicious tissue from the prostate. During the procedure, a needle is inserted into the prostate to take tissues out in order to check for prostate cancer, and this is usually done through the rectum. Doctors prefer to perform surgery on patients diagnosed with prostate cancer. If the cancer has spread to nearby tissue, doctors recommend therapies such as radiation, chemotherapy, hormone therapy, etc. to prevent cancer.
Increase in the geriatric male population globally, rise in the incidence rate of prostate cancer, and availability of advanced diagnostic systems are major factors driving the global prostate biopsy devices market. Moreover, advancements in molecular diagnosis for prostate cancer augment the global prostate biopsy system market. However, high cost of biopsy procedures and shortage of skilled professionals are major factors restraining the market.
The global prostate biopsy system market can be segmented based on product, end-user, and region. Based on product, the global prostate biopsy system market can be classified into 3D imaging systems, 2D imaging systems, and accessories. The 3D imaging system segment is projected to account for a significant share of the market in the near future, as 3D imaging systems offer a great degree of accuracy of image-guided intervention by providing optimal visualization of the prostate organ as well as full access. In terms of end-user, the prostate biopsy system market can be categorized into hospitals, diagnostic centers, and others. The hospitals segment is expected to constitute a considerable share of the market during the forecast period, because a significant number of prostate surgeries and tests are performed in hospitals due to the availability of all types of devices and reimbursement facilities.
In terms of region, the global prostate biopsy system market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market. The region is projected to account for a significant share of the global prostate biopsy system market during the forecast period. The market in the region is primarily driven by a high incidence rate of prostate cancer cases in the U.S.. According to American Cancer Society estimates, around 164,690 new cases of prostate cancer cases are likely to be registered in 2018. The scenario is almost the same in Europe due to a high incidence of death due to prostate cancer and rise in awareness about the disease in the region. According to Eurostat data, in 2015, 75.3 thousand men died from prostate cancer in the European Union. Awareness among people about the disease is a major factor propelling the market in Europe. In Asia Pacific, a developing health care infrastructure and favorable reimbursement for prostate cancer treatment are some factors that drive the market. Factors such as lack of awareness about diseases and unavailability of advanced biopsy procedures and treatment in some countries such as Iraq, Lenabon etc., are expected to hamper the prostate biopsy system market in Middle East & Africa.
Major players operating in the global prostate biopsy system market include Koninklijke Philips N.V., Eigen, 3D Biopsy Inc., BIOBOT SURGICAL PTE LTD, Cook, Boston Scientific Corporation, STERIS LAB S.r.l, and KOELIS.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.